文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

气管内滴注中性粒细胞可逆转创伤损伤相关分子模式引发的细菌过度生长

Intratracheal instillation of neutrophils rescues bacterial overgrowth initiated by trauma damage-associated molecular patterns.
PubMed 文献 · J Trauma Acute Care Surg · 2017-01-01
一句话结论小鼠模型中,气管内滴注骨髓来源中性粒细胞可恢复线粒体损伤相关分子模式抑制的肺部细菌清除,作者认为值得进一步研究作为创伤后肺炎的辅助治疗。

研究在CD-1小鼠中模拟创伤后早发性社区获得性肺炎(金黄色葡萄球菌)和晚发性医院获得性肺炎(铜绿假单胞菌),用腹腔注射线粒体损伤相关分子模式模拟肺外损伤。结果显示线粒体碎片抑制肺部细菌清除,气管内滴注骨髓来源中性粒细胞可恢复至未损伤水平,且无不良临床效应。作者结论认为气管内滴注中性粒细胞值得进一步研究,作为减少创伤患者肺部感染病情的潜在辅助治疗,并可能成为不依赖抗生素的预防或治疗手段。

要点

  • 小鼠模型中,腹腔注射线粒体损伤相关分子模式抑制肺部对金黄色葡萄球菌和铜绿假单胞菌的清除。
  • 气管内滴注骨髓来源中性粒细胞可将细菌清除恢复至未损伤水平,且对受体动物无不良临床效应。
  • 中性粒细胞滴注可清除未损伤小鼠无法清除的铜绿假单胞菌接种物。
  • 跨品系(CD-1 vs C57BL/6)气管内滴注中性粒细胞均无损伤效应。
  • 作者认为气管内滴注中性粒细胞值得进一步研究,作为创伤后肺炎的潜在辅助治疗,可能完全不依赖抗生素。

适用人群与场景

  • CD-1小鼠,模拟创伤后早发性社区获得性肺炎(金黄色葡萄球菌气管内接种)和晚发性医院获得性肺炎(铜绿假单胞菌气管内接种),伴或不伴腹腔注射线粒体损伤相关分子模式模拟肺外损伤。

处置流程与药物剂量

  • 气管内滴注骨髓来源中性粒细胞(BM-PMN),在早发性社区获得性肺炎和晚发性医院获得性肺炎模型中均将细菌清除恢复至未损伤水平。
  • 气管内滴注骨髓来源中性粒细胞可清除铜绿假单胞菌接种物,该接种物在未损伤小鼠中无法被清除。

研究设计与关键结果

  • 研究类型:动物实验(CD-1小鼠),模拟创伤后早发性社区获得性肺炎(金黄色葡萄球菌)和晚发性医院获得性肺炎(铜绿假单胞菌),以腹腔注射线粒体损伤相关分子模式模拟肺外损伤。
  • 气管内滴注骨髓来源中性粒细胞对受体动物无不良临床效应。
  • 在早发性社区获得性肺炎和晚发性医院获得性肺炎模型中,线粒体碎片抑制肺部细菌接种物清除,气管内滴注外源性骨髓来源中性粒细胞将清除恢复至未损伤水平。
  • 气管内滴注中性粒细胞可清除未损伤小鼠无法清除的铜绿假单胞菌接种物。
  • 跨品系(CD-1 vs C57BL/6)气管内滴注中性粒细胞均无损伤效应。

证据类型、等级与局限

  • 证据类型:动物实验(小鼠模型)。
  • 作者结论:这些初步研究提示气管内滴注中性粒细胞值得进一步研究,作为旨在减少创伤患者肺部感染病情的潜在辅助治疗;气管内滴注中性粒细胞可能代表一种完全不依赖抗生素需求的预防或治疗严重损伤后肺炎的独特手段。

对床旁实践的改变

  • 作者认为气管内滴注中性粒细胞值得进一步研究,作为减少创伤患者肺部感染病情的潜在辅助治疗。
  • 作者认为气管内滴注中性粒细胞可能代表一种完全不依赖抗生素需求的预防或治疗严重损伤后肺炎的独特手段。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Nosocomial pneumonias are common in trauma patients and so interventions to prevent and treat nosocomial pneumonia may improve outcomes. Our prior work strongly suggests that tissue injury predisposes to infections like nosocomial pneumonia because mitochondrial debris originating from injured cells contains damage-associated molecular patterns that can reduce neutrophil (PMN) migration into the airway and diminish PMN function in response to bacterial inoculation of the airway. This suggested that putting exogenous "normal" PMN into the airway might be beneficial.

METHODS: Postinjury pneumonia (PNA) commonly arises in two groups, early, community-acquired PNA (CAP) and later hospital-acquired PNA (HAP). Posttraumatic early-onset CAP and late-onset HAP were modeled in CD-1 mice using Staphylococcus aureus or Pseudomonas aeruginosa instilled intratracheal (i.t.) at clinically relevant times with or without extrapulmonary injuries mimicked by an intraperitoneal application of mitochondrial damage-associated molecular patterns. We applied bone marrow-derived PMN (BM-PMN) intratracheally to assess their effect on bacterial clearance in the lung.

RESULTS: BM-PMN instillation i.t. had no untoward clinical effects on recipient animals. In both the early/CAP and late/HAP models, clearance of the bacterial inoculum from the lung was suppressed by mitochondrial debris and restored to uninjured levels by i.t. instillation of exogenous BM-PMN. Furthermore, PMN instillation cleared the inoculum of P. aeruginosa that could not be cleared by uninjured mice. Instillation of PMN into the lung, even across strains (CD-1 vs. C57BL/6) had no injurious effect.

CONCLUSION: These initial studies suggest PMN instillation (i.t.) is worthy of further study as a potential adjunctive therapy aimed at decreasing the morbidity of lung infections in trauma patients. Moreover, PMN instillation (i.t.) may represent a unique means of preventing or treating pneumonia after serious injury that is completely independent of the need for antibiotic use.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Itagaki K, Riça I, Zhang J, et al. Intratracheal instillation of neutrophils rescues bacterial overgrowth initiated by trauma damage-associated molecular patterns. J Trauma Acute Care Surg. 2017. PMID: 28431414. doi:10.1097/TA.0000000000001413

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。